CD8A and neoplasm: Therefore, our observations in 8 tumor patients add additional information about the potential of [89Zr]Zr-Df-IAB22M2C to assess systemic immunological processes that are crucial for successful anticancer immune responses via the visualization of CD8+ T-cell biodistribution, migration, and homing patterns.